Cargando…
Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives
Autores principales: | Monguió-Tortajada, Marta, Bayes-Genis, Antoni, Rosell, Antoni, Roura, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815888/ https://www.ncbi.nlm.nih.gov/pubmed/33323479 http://dx.doi.org/10.1136/thoraxjnl-2020-215717 |
Ejemplares similares
-
Clinical translation of mesenchymal stromal cell extracellular vesicles: Considerations on scientific rationale and production requisites
por: Courageux, Yvan, et al.
Publicado: (2021) -
Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo
por: Monguió-Tortajada, Marta, et al.
Publicado: (2017) -
Preclinical Evaluation of the Immunomodulatory Properties of Cardiac Adipose Tissue Progenitor Cells Using Umbilical Cord Blood Mesenchymal Stem Cells: A Direct Comparative Study
por: Perea-Gil, Isaac, et al.
Publicado: (2015) -
Our Journey Through Advanced Therapies to Reduce Post-Infarct Scarring
por: Roura, Santiago, et al.
Publicado: (2021) -
N-Glycans in Immortalized Mesenchymal Stromal Cell-Derived Extracellular Vesicles Are Critical for EV–Cell Interaction and Functional Activation of Endothelial Cells
por: Clos-Sansalvador, Marta, et al.
Publicado: (2022)